Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia

G Livshits, A Kalinkovich - Ageing Research Reviews, 2024 - Elsevier
Sarcopenia is an age-associated loss of skeletal muscle mass, strength, and function,
accompanied by severe adverse health outcomes, such as falls and fractures, functional …

Microbial Synthetic Epigenetic Tools Design and Applications

I Komera, X Chen, L Liu, C Gao - ACS Synthetic Biology, 2024 - ACS Publications
Microbial synthetic epigenetics offers significant opportunities for the design of synthetic
biology tools by leveraging reversible gene control mechanisms without altering DNA …

SMYD3 promotes cell cycle progression by inducing cyclin D3 transcription and stabilizing the cyclin D1 protein in medulloblastoma

S Asuthkar, S Venkataraman, J Avilala, K Shishido… - Cancers, 2022 - mdpi.com
Simple Summary Medulloblastoma is the most common malignant pediatric brain tumor and
is classified into four molecular subgroups: Wnt, Shh, Group 3, and Group 4. Of these …

From cancer big data to treatment: Artificial intelligence in cancer research

Danishuddin, S Khan, JJ Kim - The journal of gene medicine, 2024 - Wiley Online Library
In recent years, developing the idea of “cancer big data” has emerged as a result of the
significant expansion of various fields such as clinical research, genomics, proteomics and …

Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?

MR Farani, M Sarlak, A Gholami, M Azaraian… - … -Research and Practice, 2023 - Elsevier
Epigenetics is the study of heritable changes in gene expression or function without altering
the DNA sequence. Important factors are part of epigenetic events, such as methylation …

An overview regarding pharmacogenomics and biomarkers discovery: focus on breast cancer

TB Scandolara, BR Barreto Pires… - Current Topics in …, 2022 - ingentaconnect.com
Breast cancer represents a health concern worldwide for being the leading cause of cancer-
related women's death. The main challenge for breast cancer treatment involves its …

Promises and challenges in pharmacoepigenetics

DA Smith, MC Sadler, RB Altman - Cambridge Prisms: Precision …, 2023 - cambridge.org
Pharmacogenetics, the study of how interindividual genetic differences affect drug response,
does not explain all observed heritable variance in drug response. Epigenetic mechanisms …

Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer

SP Nunes, L Morales, C Rubio… - Cell Death …, 2024 - nature.com
Alterations in the epigenetic machinery in both tumor and immune cells contribute to bladder
cancer (BC) development, constituting a promising target as an alternative therapeutic …

[HTML][HTML] Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer

W Li, H Chen, Z Wang, J Liu, X Lei… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background The Chromobox homolog 4 (CBX4) has been found to be overexpressed in
multiple malignancies. However, the associations between CBX4 and gastric cancer (GC) …

Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer

X Zhang, T Li, Q Niu, C Qin, M Zhang, G Wu… - World Journal of …, 2022 - Springer
Background Colorectal cancer is the most common malignancy and the third leading cause
of cancer-related death worldwide. This study aimed to identify potential diagnostic …